F10 and atrial fibrillation: ROCKET-AF (Rivaroxaban Once daily oral direct Factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) studied once daily Rivaroxaban demonstrating non-inferiority to warfarin with reduced intracranial and similar rate of major bleeding [76].